STU3 Candidate

This page is part of the FHIR Specification (v1.8.0: STU 3 Draft). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions

Provenance_biocompute_object_example.xml

Raw XML (canonical form)

Provenance for Biocompute object examples (id = "obj.1001")

<Provenance xmlns="http://hl7.org/fhir">
  <id value="obj.1001"/>
  <text><status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative with Details</b></p><p><b>id</b>: obj.1001</p><p><b>target</b>: <a>Procedure/example/_history/1.2</a></p><p><b>period</b>: 06/06/2017 --&gt; (ongoing)</p><p><b>recorded</b>: 09/06/2016 8:12:14 AM</p><p><b>reason</b>: antiviral resistance detection (Details: [not stated] code null = 'null', stated as
         'antiviral resistance detection')</p><p><b>policy</b>: <a>https://github.com/common-workflow-language/workflows/blob/master/workflows/lobSTR/lobSTR-workflow.c
          wl</a></p><blockquote><p><b>agent</b></p><p><b>role</b>: Author (Details: http://hl7.org/fhir/provenance-participant-role code author = 'Author',
           stated as 'null')</p><p><b>who</b>: <a>Practitioner/f204</a></p></blockquote><blockquote><p><b>agent</b></p><p><b>role</b>: Author (Details: http://hl7.org/fhir/provenance-participant-role code author = 'Author',
           stated as 'null')</p><p><b>who</b>: <a>Practitioner/f006</a></p></blockquote><blockquote><p><b>entity</b></p><p><b>role</b>: quotation</p><p><b>reference</b>: Identify baseline single nucleotide polymorphisms (SNPs[SO:0000694]), insertions[SO:0000667],
           and deletions[SO:0000045] that correlate with reduced ledipasvir[PubChem:67505836] antiviral
           drug efficacy in Hepatitis C virus subtype 1</p></blockquote><blockquote><p><b>entity</b></p><p><b>role</b>: quotation</p><p><b>reference</b>: Identify treatment emergent amino acid substitutions[SO:0000048] that correlate with
           antiviral drug treatment failure</p></blockquote><blockquote><p><b>entity</b></p><p><b>role</b>: quotation</p><p><b>reference</b>: Determine whether the treatment emergent amino acid    substitutions[SO:0000048] identified
           correlate with treatment failure    involving other drugs against the same virus</p></blockquote></div></text><target>
    <reference value="Procedure/example/_history/1.2"/>
  </target>
  <period>
    <start value="2017-06-06"/>
  </period>
  <recorded value="2016-06-09T08:12:14+10:00"/>
  <reason>
      <display value="antiviral resistance detection"/>
  </reason>
  <!--      reference to a patient consent to share inforamtion      -->
  <policy value="https://github.com/common-workflow-language/workflows/blob/master/workflows/lobSTR/lobSTR-workflow.c
  wl"/>
  
  <!--      author = Harold Hippocrates      -->
  <agent>
    <role>
      <system value="http://hl7.org/fhir/provenance-participant-role"/>
      <code value="author"/>
    </role>
     <whoReference>
    <reference value="Practitioner/f204"/>
  </whoReference>
    <!--      very often, the user won't have a known system - these aren't available 
      for security system log ons. But where you can define it, you should      -->
  </agent>

  <agent>
    <role>
      <system value="http://hl7.org/fhir/provenance-participant-role"/>
      <code value="author"/>
    </role>
    <whoReference>
    <reference value="Practitioner/f006"/>
    </whoReference>  
    <!--      very often, the user won't have a known system - these aren't available 
      for security system log ons. But where you can define it, you should      --> 
  </agent>
 
  
  <entity>
    <role value="quotation"/>
    <reference>   
      <display value="Identify baseline single nucleotide polymorphisms (SNPs[SO:0000694]), insertions[SO:0000667],
       and deletions[SO:0000045] that correlate with reduced ledipasvir[PubChem:67505836] antiviral
       drug efficacy in Hepatitis C virus subtype 1"/>     
   </reference>   
  </entity>

<entity>
  <role value="quotation"/>
  <reference>
    <display value="Identify treatment emergent amino acid substitutions[SO:0000048] that correlate with antiviral
       drug treatment failure"/>    
  </reference>
</entity>

<entity>
  <role value="quotation"/>
  <reference>
     <display value="Determine whether the treatment emergent amino acid    substitutions[SO:0000048] identified
       correlate with treatment failure    involving other drugs against the same virus"/>     
  </reference>
</entity>
</Provenance>

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.